Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 801 to 825 of about 5897

Previous 25

Website Changes

11/22/2020

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

11/22/2020

DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting

11/20/2020

PLUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FROM RESPECT™ PHASE 1 CLINICAL TRIAL IN RECURRENT GLIOBLASTOMA

11/19/2020

Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

11/19/2020

NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)

11/17/2020

xCures launches xACCESS - A new module in their AI-assisted clinical platform

11/17/2020

PLUS THERAPEUTICS ANNOUNCES WEBINAR TO PRESENT RESPECT™ GLIOBLASTOMA CLINICAL TRIAL UPDATE

11/17/2020

OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma

11/15/2020

Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study

11/13/2020

GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

11/12/2020

Novocure: A Disruptive Growth Play In Cancer Treatments

11/10/2020

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series

11/05/2020

First Patient Treated With Experimental Therapy For Deadly Childhood Brain Cancer

11/05/2020

Oncoceutics Receives Foundation Grants to Establish an Expanded Access Program for ONC201

11/04/2020

ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE AND CHANGE OF DOMAIN NAME FROM .Com to .Org

11/04/2020

Problem With News Blast Yesterday

11/03/2020

Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma

11/02/2020

The Man Behind The Musella Foundation

10/29/2020

Musella Foundation Accomplishments

10/29/2020

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

10/26/2020

Evolution of radiotherapies for brain tumors - the story of GammaTile Therapy.

10/19/2020

Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study

10/15/2020

Musella Foundation Copayment Assistance Program Closed to New patients

10/08/2020

What would YOU do if you were diagnosed with GBM?

10/04/2020

Brain TUmor Webinar Tonight!

Our privacy / cookie policy has changed.
Click HERE to read it!